Art of the Kill: Designing and Testing Viral Inactivation Procedures for Highly Pathogenic Negative Sense RNA Viruses

Judith Olejnik1,2, Adam J Hume1,2, Stephen J Ross1,2,3

  • 1Department of Virology, Immunology and Microbiology, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.

PubMed

Insights

This study validates inactivation methods for highly pathogenic viruses like Ebola, Nipah, and Lassa, crucial for safe sample transfer from BSL-4 labs. It emphasizes clear parameter definition for heat inactivation and provides documentation templates for regulatory compliance.

Area of Science:

  • Virology
  • Biosafety
  • Laboratory Science

Background:

  • Handling highly pathogenic viruses under Biosafety Level 4 (BSL-4) conditions requires validated inactivation methods for safe transfer of materials for downstream analysis.
  • Select Agent regulations and BSL-4 safety protocols mandate rigorous validation of inactivation procedures, presenting challenges with cytotoxic reagents and precise parameter definition.

Purpose of the Study:

  • To provide a workflow and practical solutions for validating virus inactivation methods for highly pathogenic viruses.
  • To address challenges associated with chemical and physical inactivation methods for viruses like Ebola, Nipah, and Lassa.
  • To offer templates for documentation required for inactivation Standard Operating Procedures (SOPs) and sample tracking.

Main Methods:

  • Evaluation of three distinct inactivation methods: chemical inactivation (TRIzol/TRIzol LS), aldehyde fixation, and heat inactivation.
  • Application of methods to model viruses including Ebola, Nipah, and Lassa viruses.
  • Development and presentation of documentation templates for inactivation SOPs and reports.

Main Results:

  • Published chemical inactivation methods demonstrated high reliability for virus inactivation.
  • Heat inactivation requires clearly defined parameters to ensure complete inactivation of viruses.
  • Successful demonstration of a workflow for inactivation validation and documentation.

Conclusions:

  • Validated inactivation protocols are essential for the safe transfer of viral materials from high-containment laboratories.
  • Standardized documentation, including inactivation reports and certificates, facilitates regulatory compliance and sample traceability.
  • The provided workflow serves as a guide for laboratories working with high-containment viruses and inactivation procedures.